Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT05885971
Recruiting Not applicable

Detection of Eating Disorders in Pregnant Women

NCT05885971 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier Henri Laborit
Phase
Not applicable
Started
2023-06-30
Last updated
2026-01-13

Condition(s) studied

Eating DisordersPregnancy Related

Investigational drug(s) / intervention(s)

Administration of the SCOFF-F and EDE-Q questionnaires

Administration of the SCOFF-F and EDE-Q questionnaires: The participants will answer to the SCOFF-F and EDE-Q questionnaires as well as socio-demographic questions

Study summary

Eating disorders (ED) are insufficiently detected and belatedly or not treated during pregnancy.

There are many screening questionnaires for eating disorders in the literature, but we note the absence of a specific and validated tool for their screening during pregnancy, which would make it possible to differentiate maternal dietary concerns related to pregnancy from symptoms linked to a proven eating disorder.

The main objective of the study is to evaluate which items of the Sick Control One stone Fat Food (SCOFF-F) and Eating disorders examination questionnaire (EDE-Q) questionnaires could be specific to an ED during pregnancy and not related to the simple state of pregnancy, by comparing the answers of pregnant women, for whom the diagnosis of ED has been made, to those of pregnant women without an ED.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adult pregnant woman * Woman with current diagnosed Eating Disorders or without Eating Disorders * Having a good command of the French language * Having given their consent for their participation in the research Exclusion Criteria: * Underage pregnant woman * Woman who does not have a good command of the French language. * Woman with past Eating Disorders

Primary outcome measure(s)

  • Specific Eating Disorders items in pregnant women — 36 months
    A discriminant factor analysis will be used to study whether there are elements that can distinguish women with an Eating Disorders from those who do not have one during pregnancy.

Trial sites (1)

FacilityCityRegionStatus
Centre Hospitalier Henri Laborit Poitiers France Recruiting

More Centre Hospitalier Henri Laborit trials in France

French Observatory of ElectroConvulsive Therapy (ECT) Recruiting
Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders Recruiting
tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder Recruiting
Evaluation of Membrane Phospholipid and Energy Metabolism in Subjects at High Risk of Psychotic Transition Recruiting
tDCS and Symptom Provocation in Treatment-Resistant OCD Starting soon

Other trials for the same condition

Study of the Effectiveness of a Systematic Minimal Early Intervention on Care Engagement in Adults With Eating Disorders Requesting Specialized Treatment. Recruiting
PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism Recruiting
Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders Starting soon
Overview of Knowledge and Practices Among Healthcare Professionals Treating Eating Disorders Recruiting
Inertial Sensors for Obstetrical Walking Epidural Tracking Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05885971 on ClinicalTrials.gov ↗ ← All trials in France